In ovarian and endometrial cancer, VISTA can significantly inhibit T cell proliferation and cytokine IFN-γ production, especially for tumor infiltration CD8+ T cells, and it also proves that the downregulation of VISTA in endometrial cancer cells can restore T cell proliferation and cytokine production [42, 55]. Here, VSIR is linked to neoplasm.